Several studies have shown that glycyrrhizic acid and its hydrolyzed product glycyrrhetinic acid can reduce the size of cerebral infarction, restore motor function, inhibit M1 microglia activation, enhance M2 activation, and induce neural regeneration by inhibiting HMGB1 [63, 71]. Here, HMGB1 is linked to cerebral infarction.